LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
ICA to screen Independent documentary amid unprecedented cuts to global HIV/AIDs response - To mark World AIDS Day, the ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
Either we get ahead of this crisis or watch a generation of Americans be swept into the devastating grip of disease.
Preeclampsia is a complex, multisystem disorder associated with pregnancy, characterized primarily by proteinuria and ...
6h
NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback